chr5-148089550-G-A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_006846.4(SPINK5):​c.531G>A​(p.Arg177Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0229 in 1,612,058 control chromosomes in the GnomAD database, including 833 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 106 hom., cov: 32)
Exomes 𝑓: 0.022 ( 727 hom. )

Consequence

SPINK5
NM_006846.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.251

Publications

5 publications found
Variant links:
Genes affected
SPINK5 (HGNC:15464): (serine peptidase inhibitor Kazal type 5) This gene encodes a multidomain serine protease inhibitor that contains 15 potential inhibitory domains. The encoded preproprotein is proteolytically processed to generate multiple protein products, which may exhibit unique activities and specificities. These proteins may play a role in skin and hair morphogenesis, as well as anti-inflammatory and antimicrobial protection of mucous epithelia. Mutations in this gene may result in Netherton syndrome, a disorder characterized by ichthyosis, defective cornification, and atopy. This gene is present in a gene cluster on chromosome 5. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
FBXO38-DT (HGNC:55589): (FBXO38 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 5-148089550-G-A is Benign according to our data. Variant chr5-148089550-G-A is described in ClinVar as Benign. ClinVar VariationId is 139255.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.251 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0862 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPINK5NM_006846.4 linkc.531G>A p.Arg177Arg synonymous_variant Exon 7 of 33 ENST00000256084.8 NP_006837.2 Q9NQ38-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPINK5ENST00000256084.8 linkc.531G>A p.Arg177Arg synonymous_variant Exon 7 of 33 1 NM_006846.4 ENSP00000256084.7 Q9NQ38-1

Frequencies

GnomAD3 genomes
AF:
0.0292
AC:
4429
AN:
151700
Hom.:
104
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0501
Gnomad AMI
AF:
0.00987
Gnomad AMR
AF:
0.0148
Gnomad ASJ
AF:
0.0242
Gnomad EAS
AF:
0.0452
Gnomad SAS
AF:
0.0939
Gnomad FIN
AF:
0.0128
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0169
Gnomad OTH
AF:
0.0316
GnomAD2 exomes
AF:
0.0313
AC:
7800
AN:
248882
AF XY:
0.0337
show subpopulations
Gnomad AFR exome
AF:
0.0508
Gnomad AMR exome
AF:
0.0131
Gnomad ASJ exome
AF:
0.0263
Gnomad EAS exome
AF:
0.0508
Gnomad FIN exome
AF:
0.0105
Gnomad NFE exome
AF:
0.0190
Gnomad OTH exome
AF:
0.0251
GnomAD4 exome
AF:
0.0223
AC:
32509
AN:
1460240
Hom.:
727
Cov.:
32
AF XY:
0.0245
AC XY:
17822
AN XY:
726450
show subpopulations
African (AFR)
AF:
0.0505
AC:
1684
AN:
33366
American (AMR)
AF:
0.0141
AC:
631
AN:
44610
Ashkenazi Jewish (ASJ)
AF:
0.0277
AC:
721
AN:
26046
East Asian (EAS)
AF:
0.0343
AC:
1361
AN:
39662
South Asian (SAS)
AF:
0.0933
AC:
8043
AN:
86230
European-Finnish (FIN)
AF:
0.0114
AC:
608
AN:
53420
Middle Eastern (MID)
AF:
0.0278
AC:
160
AN:
5752
European-Non Finnish (NFE)
AF:
0.0160
AC:
17762
AN:
1110890
Other (OTH)
AF:
0.0255
AC:
1539
AN:
60264
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
2108
4216
6324
8432
10540
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
734
1468
2202
2936
3670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0291
AC:
4425
AN:
151818
Hom.:
106
Cov.:
32
AF XY:
0.0289
AC XY:
2148
AN XY:
74198
show subpopulations
African (AFR)
AF:
0.0500
AC:
2072
AN:
41440
American (AMR)
AF:
0.0148
AC:
225
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.0242
AC:
84
AN:
3464
East Asian (EAS)
AF:
0.0449
AC:
229
AN:
5100
South Asian (SAS)
AF:
0.0934
AC:
450
AN:
4820
European-Finnish (FIN)
AF:
0.0128
AC:
136
AN:
10602
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0169
AC:
1144
AN:
67850
Other (OTH)
AF:
0.0313
AC:
66
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
214
428
642
856
1070
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0223
Hom.:
29
Bravo
AF:
0.0295
Asia WGS
AF:
0.0520
AC:
181
AN:
3478
EpiCase
AF:
0.0200
EpiControl
AF:
0.0179

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Ichthyosis linearis circumflexa Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Netherton syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.39
CADD
Benign
14
DANN
Benign
0.80
PhyloP100
0.25
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35121983; hg19: chr5-147469113; COSMIC: COSV56250648; COSMIC: COSV56250648; API